GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 39 filers reported holding GALERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $107,375 | -94.4% | 613,223 | 0.0% | 0.09% | -92.9% |
Q2 2023 | $1,913,256 | +21.9% | 613,223 | 0.0% | 1.22% | +14.5% |
Q1 2023 | $1,569,851 | +71.8% | 613,223 | 0.0% | 1.07% | +69.5% |
Q4 2022 | $913,702 | -14.4% | 613,223 | 0.0% | 0.63% | -7.5% |
Q3 2022 | $1,067,000 | +33.9% | 613,223 | 0.0% | 0.68% | +24.5% |
Q2 2022 | $797,000 | -45.4% | 613,223 | 0.0% | 0.55% | -21.0% |
Q1 2022 | $1,459,000 | -48.2% | 613,223 | 0.0% | 0.69% | -16.9% |
Q4 2021 | $2,815,000 | -43.3% | 613,223 | 0.0% | 0.83% | -47.6% |
Q3 2021 | $4,967,000 | -17.6% | 613,223 | 0.0% | 1.59% | -15.1% |
Q2 2021 | $6,028,000 | – | 613,223 | – | 1.87% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 3,083,712 | $40,582,000 | 2.92% |
Novo Holdings A/S | 3,409,021 | $44,863,000 | 2.89% |
NEA Management Company, LLC | 4,362,986 | $57,417,000 | 2.72% |
SPHERA FUNDS MANAGEMENT LTD. | 471,439 | $6,204,000 | 0.51% |
RA Capital Management | 1,054,178 | $13,873,000 | 0.42% |
Rock Springs Capital Management LP | 500,000 | $6,580,000 | 0.21% |
Tekla Capital Management LLC | 416,666 | $5,483,000 | 0.21% |
Blackstone Inc. | 1,678,984 | $22,095,000 | 0.14% |
Perceptive Advisors | 325,000 | $4,277,000 | 0.08% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,300,000 | $17,108,000 | 0.04% |